Skip to content
Alembic logo

Alembic

ALEMBICLTD NSE
₹87.59 0.37 (0.42%)
Market Cap
₹2,249 Cr
P/E
7.02

Alembic (ALEMBICLTD) share price was ₹87.59 at the 28 Oct 2026 close; market capitalisation ₹2,249 Cr; P/E (TTM) 7.02; sector Realty. The share price fell 11.4% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue fell 2.2% year on year to ₹48.7 Cr and net profit rose 5.4% year on year to ₹64.9 Cr (compared with Jun 2025). Promoters held 71.41% of Alembic in Sep 2026, up 0.53 percentage points from Jun 2026. Its Tapetide Score is 62/100 (Good) as of 28 Oct 2026.

Close 28 Oct 2026 ₹87.59 −11.24 −11.37% 1Y

Key Fundamentals

MicrocapRealtyConsumer Discretionary
Market Cap
₹2,249 Cr
P/E (TTM)
7.02
EBITDA
₹163 Cr
Return on Equity
5.15%
Debt to Equity
0
Book Value
₹95.22
EPS (TTM)
₹12.48
52W High
₹117.72
52W Low
₹70.46

Price-based figures as of 28 Oct 2026, 15:31 IST · EPS basis: Consolidated · TTM

Peer Comparison

Consumer Discretionary › Realty › Residential Commercial Projects › Residential, Commercial Projects

₹666.3036.111,64,930 Cr3.621.19%5.77%6.35%8,504 Cr4,567 Cr
₹1,007.1024.381,00,643 Cr4.410.42%14.64%18.07%18,603 Cr4,129 Cr
₹1,899.3053.0767,934 Cr6.180.13%10.88%11.84%4,724 Cr1,629 Cr
₹1,392.2052.6459,966 Cr3.690.14%7.80%12.91%13,597 Cr1,265 Cr
₹1,601.0022.1358,213 Cr3.050.25%13.99%16.74%6,501 Cr2,632 Cr
₹1,587.0029.8747,805 Cr2.470.63%9.51%12.01%8,849 Cr1,591 Cr
₹538.3525.2717,564 Cr2.580.36%9.63%9.89%5,805 Cr784 Cr
Alembic (this company)
₹87.597.022,249 Cr0.922.75%5.15%6.07%314 Cr320 Cr
Median 8 companies₹1,199.6527.5759,089 Cr3.340.39%9.57%11.93%7,503 Cr1,610 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100. How it works →

As of 2026-10-28
v2.0.0
62 Good
Overall score
Data confidence 100/100

Category scores

Quality Good 58
Returns, margins, earnings quality 22%
Valuation Strong 75
Cheap vs sector & own history 24%
Growth Weak 40
Sales & profit trajectory 9%
Financial Health Strong 90
Solvency, leverage, coverage 9%
Momentum Weak 38
Trend strength, vol-adjusted 12%
Ownership Good 60
FII/DII/promoter flows 24%

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

4
  • Company has reduced debt.
  • Company is almost debt free.
  • Stock is trading at 1.02 times its book value
  • Company has been maintaining a healthy dividend payout of 20.7%

Weaknesses

2
  • Company has a low return on equity of 13.1% over last 3 years.
  • Earnings include an other income of Rs.75.3 Cr.

Technical Indicators

Oscillators

BearishNeutralBullish

Neutral

Bearish
2
Neutral
5
Bullish
2

Overall

BearishNeutralBullish

Bearish

Bearish
12
Neutral
5
Bullish
2

Moving Averages

BearishNeutralBullish

Bearish

Bearish
10
Neutral
0
Bullish
0

Growth Rate

Revenue Growth
5.46% lower than 3Y

change over 1 year

Net Income Growth
-12.93% lower than 3Y

change over 1 year

Cash Flow Change
39.02%

change over 1 year

EBITDA Margin Change
-8.08%

change over 1 year Operating margin 32% · Jun 2026

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
37
32
39
49
51
53
58
60
50
56
74
60
49
Expenses
26
22
28
25
30
33
32
33
30
33
47
40
33
Operating Profit
11
10
12
24
20
20
26
27
20
23
27
20
15
OPM %
30%
31%
30%
49%
40%
37%
46%
45%
39%
42%
37%
34%
32%
Other Income
3
48
2
2
2
66
4
3
4
65
2
2
6
Interest
0
0
0
0
0
1
1
1
1
1
1
1
1
Depreciation
2
2
3
1
2
3
3
3
3
3
3
3
3
PBT
12
56
11
24
19
82
27
27
20
85
26
18
17
Tax %
14%
8%
9%
12%
10%
6%
5%
12%
10%
10%
13%
48%
9%
Net Profit
44
91
61
72
56
121
65
68
62
128
60
67
65
EPS (₹)
1.73
3.53
2.39
2.81
2.17
4.71
2.55
2.67
2.4
5
2.34
2.61
2.53
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
144
134
147
125
124
74
74
78
127
157
222
240
239
Expenses
134
128
140
114
106
71
62
64
87
101
128
150
153
Operating Profit
10
6
7
11
18
3
11
14
40
57
94
90
86
OPM %
7%
4.6%
4.6%
9%
15%
4.4%
15%
18%
32%
36%
42%
38%
36%
Other Income
21
25
25
37
29
93
10
89
54
55
75
73
75
Interest
1
0
0
0
0
0
0
0
0
1
2
2
2
Depreciation
6
6
5
4
3
3
4
5
7
8
11
12
13
PBT
23
25
27
44
45
93
17
98
87
103
156
149
146
Tax %
-3%
2%
-3%
5%
8%
0%
19%
12%
7%
10%
7%
15%
—
Net Profit
107
235
145
163
213
329
343
222
191
269
311
317
321
EPS (₹)
3.99
8.78
5.45
6.1
8.3
12.82
13.35
8.65
7.42
10.46
12.1
12.36
12.48
Div. Payout %
4%
2%
4%
3%
2%
5%
2%
21%
30%
23%
20%
19%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
53
53
53
53
51
51
51
51
51
51
51
51
Reserves
474
750
858
1,032
1,157
1,367
2,246
2,445
2,027
2,134
2,287
2,394
Borrowings
0
9
0
0
0
0
0
0
0
9
14
11
Other Liabilities
91
64
81
73
57
53
112
135
127
134
150
134
Total Liabilities
619
875
992
1,159
1,266
1,471
2,409
2,632
2,205
2,329
2,503
2,590
Fixed Assets
169
146
171
179
209
225
265
297
321
369
409
472
CWIP
2
0
0
0
0
3
6
0
0
1
0
2
Investments
299
605
732
913
1,001
1,133
2,047
2,208
1,754
1,786
1,900
1,974
Other Assets
149
124
89
67
55
110
91
127
130
173
194
142
Total Assets
619
875
992
1,159
1,266
1,471
2,409
2,632
2,205
2,329
2,503
2,590
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
22
10
52
24
22
7
-2
-18
39
23
86
120
Investing
5
-5
-47
-22
68
57
-35
19
7
26
-27
-54
Financing
-25
-5
-5
-3
-89
-6
-15
-6
-46
-48
-58
-68
Net Cash Flow
2
0
0
-1
1
57
-52
-5
0
0
1
-1
Free Cash Flow
22
11
38
14
-1
-15
-49
-51
14
-33
36
43
CFO/EBITDA
222
172
771
245
145
246
0
-63
112
39
109
154
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
122
76
54
74
40
44
69
71
67
46
49
49
Inventory Days
880
659
438
247
289
411
2,112
2,885
—
3,694
—
1,161
Days Payable
200
144
128
125
202
151
693
640
—
1,237
—
530
Cash Conversion Cycle
801
591
364
195
126
305
1,488
2,316
67
2,502
49
679
Working Capital Days
235
172
39
20
13
22
97
223
118
77
57
-6
ROCE %
—
4%
4%
4%
4%
7%
1%
4%
4%
5%
7%
6%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Alembic insights

61 extracted metrics + investor summaries across FY12–FY27.

Shareholding Pattern

DIIs0.05%Promot.71.41%FIIs1.34%Others5.90%Public21.29%As ofSep 2026

Documents

Frequently Asked Questions about Alembic

What does Alembic Ltd do?
Alembic Limited is engaged in the businesses of Pharmaceuticals, Real Estate, and Power Assets. The company was started in 1907 as the flagship company of the Alembic Group. In 2010, the company demerged its core pharmaceutical business (formulations) into a wholly-owned subsidiary, Alembic Pharm...
Where is Alembic Ltd (ALEMBICLTD) listed?
Alembic Ltd trades as ALEMBICLTD on the NSE and under code 506235 on the BSE.
Which sector does Alembic Ltd belong to?
Alembic Ltd is classified under the Realty sector, in the Residential Commercial Projects industry.
What is the market capitalisation of Alembic Ltd?
Alembic Ltd has a market capitalisation of ₹2,249 Cr as of 28 Oct 2026, which places it in the Small Cap band.
What is the PE ratio of Alembic Ltd?
Alembic Ltd trades at a PE ratio of 7.02 as of 28 Oct 2026, on earnings per share of ₹12.48, against a book value of ₹95.22 per share.
What is the 52-week high and low of Alembic Ltd?
Over the last 52 weeks Alembic Ltd has traded between ₹70.46 and ₹117.72 as of 28 Oct 2026.
Does Alembic Ltd pay dividends?
Alembic Ltd has a dividend yield of 2.75%.
What is the Return on Equity (ROE) of Alembic Ltd?
Alembic Ltd reported a return on equity of 5.15%. Its debt-to-equity ratio is 0.00.

Company Information

Alembic Limited is engaged in the businesses of Pharmaceuticals, Real Estate, and Power Assets. The company was started in 1907 as the flagship company of the Alembic Group. In 2010, the company demerged its core pharmaceutical business (formulations) into a wholly-owned subsidiary, Alembic Pharma Ltd and after the demerger, APL became the flagship company of the Alembic Group. With its registered office in Vadodra, Alembic Ltd currently holds a 28.41% stake in Alembic Pharma Ltd and a 19.01% stake in another group entity Paushak Limited.[1]

CEO Mr. Udit C. Amin
Employees 256
Listed 1999-09-22
Face Value ₹ 2
Shares Outstanding 25,67,81,828

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/ALEMBICLTD.md for Alembic Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More